an advanced cell technology blog

ACT's Company Blog.

Advanced Cell Technology, Inc. (OTCBB: ACTC) is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit www.advancedcell.com.

  • Company Blog
  • ACTC.OBTerms of use
  • Contact

These are the posts from June 2010

June 11, 2010
Posted by admin

NIH Approves Advanced Cell Technology’s Stem Cell Line for Federal Funding

Access to Federal Funding Could Accelerate Clinical Development
June 11, 2010, WORCESTER, MA – Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC) announced today that human embryonic stem cell (hESC) line MA135 was unanimously approved for federal funding at the 100th Meeting of the Advisory Committee to the Director (ACD) National Institutes of Health (NIH). In addition [...]

1 Comment

Posted Under Uncategorized


     

    ACT Publishes...

    Uncategorized

     

    Scientific...

    Uncategorized

     

    ACT and Roslin...

    Uncategorized

    Gary Rabin Chairman's Blog: Timing and Pace of Our Clinical Trials http://t.co/I6YfXPDc #SMD #DryAMD #hESCs

    follow me on
    twitter

    ACTC.OB Stock Quote


    Advanced Cell Tecchart +0.00%

    2012-02-22 15:59
  • Categories

    • ACT Events
    • Biotechnology
      • Regenerative
    • human trials
    • Stock Talk
      • Governance
      • Reports
    • Uncategorized
  • Archives

    • 2012
      • January
    • 2011
      • January
      • February
      • March
      • April
      • May
      • June
      • October
    • 2010
      • January
      • February
      • March
      • April
      • May
      • June
      • July
      • August
      • September
      • November
      • December
  • Facebook

    ACT Links

    • Biotech Investors Network
    • Medical Technology
    • Patient Support Group
    • LinkedIn Company page
    • Facebook Company page
    • Twitter Company page
    • Google Groups
    • Chairmans blog RSS feed

Powered by WordPress: this website is official and sanctioned by Advanced Cell Technology.